首页 > 市场调查报告书 > 製药

消化器

市场调查报告书

商品编码

1630773

急性胰臟炎市场规模、份额和成长分析（按诊断、原因、治疗、最终用户和地区）- 产业预测 2025-2032

Acute Pancreatitis Market Size, Share, Growth Analysis, By Diagnosis (Imaging Tests, Laboratory Tests), By Cause (Gallstones, Alcohol), By Treatment, By End user, By Region - Industry Forecast 2025-2032

出版日期: 2025年01月09日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

全球急性胰臟炎市场规模预计将在 2023 年达到 58 亿美元，从 2024 年的 61.4 亿美元成长到 2032 年的 97.2 亿美元，预测期内（2025-2032 年）的复合年增长率为 5.9%。

受病例数量的增加和医疗治疗的重大进步的推动，全球急性胰臟炎市场正在迅速发展。严重的胰臟炎会带来严重的健康风险，推动对有效的诊断、治疗和管理解决方案的需求。主要的市场驱动因素包括因肥胖、饮酒和胆结石等风险因素导致的盛行率增加、诊断技术的改进和新的治疗方案。这是一个竞争激烈的领域，製药公司、医疗设备製造商和医疗保健提供者积极进行研究、临床试验和策略联盟，以增强其产品供应。持续的创新和合作预计将塑造市场的未来，旨在改善患者的治疗效果并解决与这种严重健康状况相关的复杂问题。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲国家
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前 5 家公司对比
主要企业市场定位（2024年）
主要市场参与者所采用的策略
近期市场趋势
公司市场占有率分析（2024 年）
主要企业简介
- 公司简介
- 产品系列分析
- 按细分市场分析市场份额
- 收益与前一年同期比较（2022-2024 年）

主要企业简介

Pfizer Inc.（United States）
Merck & Co., Inc.（United States）
Baxter International Inc.（United States）
Abbott Laboratories（United States）
B. Braun SE（Germany）
CalciMedica Inc.（United States）
Dynavax Technologies Corporation（United States）
Fresenius SE & Co. KGaA（Germany）
GlaxoSmithKline plc（United Kingdom）
Olympus Corporation（Japan）
SCM Lifescience（South Korea）
Samsung Bioepis（South Korea）
GNT Pharma Co.（South Korea）
Medtronic plc（Ireland）
Boston Scientific Corporation（United States）
Takeda Pharmaceuticals（Japan）
Novartis AG（Switzerland）
AbbVie Inc.（United States）
General Electric Company（United States）
Mitsubishi Tanabe Pharma Corporation（Japan）

结论和建议

简介目录

Product Code: SQMIG35D2197

Global Acute Pancreatitis Market size was valued at USD 5.8 billion in 2023 and is poised to grow from USD 6.14 billion in 2024 to USD 9.72 billion by 2032, growing at a CAGR of 5.9% during the forecast period (2025-2032).

The global acute pancreatitis market is evolving rapidly, fueled by rising case numbers and significant medical advancements. This severe pancreatic inflammation poses serious health risks, resulting in a growing demand for effective diagnosis, treatment, and management solutions. Key market drivers include increased prevalence attributed to risk factors like obesity, alcohol consumption, and gallstones, alongside improvements in diagnostic technologies and novel therapeutic options. The sector is highly competitive, with pharmaceutical firms, medical device manufacturers, and healthcare providers actively engaged in research, clinical trials, and strategic alliances to enhance their offerings. Continuous innovation and collaboration are anticipated to shape the market's future, aiming to improve patient outcomes and address the complexities associated with this critical health condition.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Acute Pancreatitis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Acute Pancreatitis Market Segmental Analysis

Global Acute Pancreatitis Market is segmented by Diagnosis, Cause, Treatment, End user and region. Based on Diagnosis, the market is segmented into Imaging Tests and Laboratory Tests. Based on Cause, the market is segmented into Gallstones, Alcohol and Others. Based on Treatment, the market is segmented into Intravenous fluid, Nutritional support, Analgesics, Endoscopic Retrograde Cholangiopancreatography (ERCP) and Others. Based on End user, the market is segmented into Hospitals, Clinics, Diagnostic Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Acute Pancreatitis Market

The Global Acute Pancreatitis market is expected to experience significant growth driven by the rising prevalence of diabetes, which can be exacerbated by pancreatitis as it damages insulin-producing cells in the pancreas. Approximately 45% of individuals with chronic pancreatitis eventually develop diabetes, highlighting a crucial link between these conditions. Furthermore, the market is supported by an aging population and proactive government initiatives aimed at enhancing awareness and education regarding pancreatic health. Additionally, changing consumer lifestyles, increasing obesity rates, and the potential rise in pancreatic cancer cases will further contribute to the expansion of the Acute Pancreatitis market.

Restraints in the Global Acute Pancreatitis Market

The Global Acute Pancreatitis market faces several significant restraints that may hinder its growth. One of the primary challenges is the high cost associated with treatment, which can limit accessibility for patients. Furthermore, developing economies may struggle with inadequate healthcare infrastructure, complicating treatment access and reducing market expansion potential. Additionally, a stringent regulatory environment adds another layer of complexity, while poor reimbursement practices deter patients from seeking necessary care. Lastly, a lack of public awareness about Acute Pancreatitis further stifles market growth, as it reduces the urgency for innovative treatments and interventions. These factors collectively contribute to a slow market development trajectory.

Market Trends of the Global Acute Pancreatitis Market

The global acute pancreatitis market is currently experiencing notable trends that emphasize early diagnosis and personalized treatment strategies. Increased investment in advanced diagnostic technologies aims to facilitate the swift identification of acute pancreatitis, allowing for timely therapeutic intervention and reduced complication rates. Furthermore, there is a rising inclination towards precision medicine, driven by advancements in genetic profiling and molecular diagnostics that allow for customized treatment plans. Additionally, the integration of digital health solutions is revolutionizing patient management and monitoring. Collectively, these trends are driving innovation in therapies, improving patient outcomes, and enhancing overall care in the acute pancreatitis landscape.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technological Advancement

Global Acute Pancreatitis Market Size by Diagnosis & CAGR (2025-2032)

Market Overview
Imaging Tests
Laboratory Tests

Global Acute Pancreatitis Market Size by Cause & CAGR (2025-2032)

Market Overview
Gallstones
Alcohol
Others

Global Acute Pancreatitis Market Size by Treatment & CAGR (2025-2032)

Market Overview
Intravenous fluid
Nutritional support
Analgesics
Endoscopic Retrograde Cholangiopancreatography (ERCP)
Others

Global Acute Pancreatitis Market Size by End user & CAGR (2025-2032)

Market Overview
Hospitals
Clinics
Diagnostic Centers
Others

Global Acute Pancreatitis Market Size & CAGR (2025-2032)

North America (Diagnosis, Cause, Treatment, End user)
- US
- Canada
Europe (Diagnosis, Cause, Treatment, End user)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Diagnosis, Cause, Treatment, End user)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Diagnosis, Cause, Treatment, End user)
- Brazil
- Rest of Latin America
Middle East & Africa (Diagnosis, Cause, Treatment, End user)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Pfizer Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co., Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Baxter International Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun SE (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CalciMedica Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dynavax Technologies Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fresenius SE & Co. KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline plc (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Olympus Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SCM Lifescience (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Samsung Bioepis (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GNT Pharma Co. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takeda Pharmaceuticals (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AbbVie Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
General Electric Company (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mitsubishi Tanabe Pharma Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments